What volume of sterile, bacteriostatic water should be used to reconstitute a 50mg vial of GHK-Cu (Glycyl-Histidyl-Lysine-Copper) peptide for cosmetic or dermatological use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Reconstitution Volume for GHK-Cu Peptide

For a 50mg vial of GHK-Cu peptide, add 5mL of bacteriostatic water to achieve a standard 10mg/mL concentration, which is the most commonly used concentration for cosmetic and dermatological applications.

Reconstitution Protocol

Standard Concentration Calculation

  • The 10mg/mL concentration (achieved by adding 5mL to 50mg) provides a practical dosing range that aligns with typical subcutaneous or topical application protocols 1
  • This concentration allows for precise dosing adjustments: each 0.1mL contains 1mg of GHK-Cu 1
  • Alternative concentrations can be prepared based on specific protocols, but 10mg/mL represents the most versatile starting point 1

Sterile Technique Requirements

All reconstitution must follow strict aseptic protocols to prevent contamination:

  • Sanitize the vial stopper with 70% isopropanol before needle puncture 2
  • Use only sterile needles and syringes, avoiding any direct contact contamination 2
  • Thoroughly wash hands to wrists with detergent or soap and potable water, or use 70% isopropanol sanitizing agents 2
  • Prepare in a clean, sanitized area treated with 70% isopropanol 2

Reconstitution Steps

  • Draw 5mL of bacteriostatic water into a sterile syringe 2, 1
  • Inject the bacteriostatic water slowly into the 50mg peptide vial, directing the stream against the vial wall rather than directly onto the powder 1
  • Gently swirl (do not shake vigorously) until the powder is completely dissolved 1
  • Perform visual inspection for particulate matter, discoloration, or cloudiness before use 1
  • Label the vial clearly with the concentration (10mg/mL), reconstitution date, and beyond-use date 2

Storage and Stability

Post-Reconstitution Storage

  • Store reconstituted GHK-Cu at 4°C (refrigerated) to maximize stability 1
  • Bacteriostatic water contains preservatives that extend multi-dose vial stability, but refrigeration is still recommended 1
  • Discard if any visible particulates, cloudiness, or discoloration develops 1

Important Caveats

Concentration Flexibility

  • If your specific protocol requires a different concentration, adjust the volume accordingly using the formula: Volume (mL) = Dose (mg) ÷ Desired Concentration (mg/mL) 1
  • For example, 2.5mL would yield 20mg/mL for more concentrated dosing 1

Quality Considerations

  • GHK-Cu (with copper) has demonstrated superior biological activity compared to copper-free GHK in wound healing and tissue remodeling applications 3, 4
  • The copper chelate form enhances antioxidant and anti-inflammatory bioavailability 5
  • Ensure your peptide source is pharmaceutical grade and intended for the specific application (cosmetic vs. research) 6

Common Pitfalls to Avoid

  • Never use sterile water without preservatives for multi-dose vials, as this increases contamination risk 2
  • Avoid vigorous shaking, which can denature the peptide structure 1
  • Do not use if the solution appears cloudy or contains visible particles after reconstitution 1
  • Maintain a preparation log documenting the reconstitution date, lot numbers, and expiration dates 2

References

Guideline

Reconstitution of Retatrutide 12mg Powder Vial

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Stem cell recovering effect of copper-free GHK in skin.

Journal of peptide science : an official publication of the European Peptide Society, 2012

Research

The potential of GHK as an anti-aging peptide.

Aging pathobiology and therapeutics, 2020

Related Questions

Is glycyl-L-histidyl-L-lysine-copper (GHK-Cu) safe and effective for use as an injection?
What is the recommended frequency of GHK-Cu (Glycyl-Histidyl-Lysine-Copper) injections?
What is GHK-CU (Glycine-Histidine-Lysine-Copper) and how is it used for wound healing?
What are the recommendations for using GHK-Cu (Copper-Glycine-Histidine-Lysine) in a healthy adult for anti-aging and wellness?
What is the effect of Copper-GHK (Copper-Glycyl-Histidyl-Lysine)?
Can a patient with Small Intestine Bacterial Overgrowth (SIBO) and iron deficiency develop peripheral neuropathy while taking rifaximin (antibiotic)?
What is the recommended management for a patient with chronic microvascular ischemic changes, Dandy-Walker variant, colpocephaly, and straightening of the cervical lordotic curvature, as shown on their MRI scan of the head?
Can hyperglycemia (high blood sugar) cause elevated lactate levels in patients, particularly those with diabetes or impaired glucose regulation?
What carb ratio adjustment is needed for a patient with increasing insulin requirements from 2.5 to 10 units over 3 hours for the same carb coverage of 1 per 12?
What is the line of management for a 20-year-old female with fever, dry cough, weight loss, loss of appetite, elevated Rheumatoid Arthritis (RA) factor, positive anti-Cyclic Citrullinated Peptide (anti-CCP), raised Anti-Streptolysin O (ASO) titer, and elevated C-Reactive Protein (CRP), with a Computed Tomography (CT) thorax suggestive of pulmonary tuberculosis (TB) and no history of joint pain?
What is the recommended dosage of Cetirizine (antihistamine) for a 7-year-old child with allergies?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.